- Home
- ROIV vs DOW Comparison
ROIV vs DOW Comparison
Compare ROIV & DOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ROIV | DOW |
|---|---|---|
| Founded | 2014 | 1897 |
| Country | United Kingdom | United States |
| Employees | N/A | 35700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 20.7B | 18.9B |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ROIV | DOW |
|---|---|---|
| Price | $27.08 | $38.42 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 16 |
| Target Price | $28.94 | ★ $37.06 |
| AVG Volume (30 Days) | 4.5M | ★ 14.3M |
| Earning Date | 05-28-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 3.63% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $29,053,000.00 | ★ $39,968,000,000.00 |
| Revenue This Year | N/A | $5.40 |
| Revenue Next Year | $744.61 | $2.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.58 | $20.40 |
| 52 Week High | $30.33 | $42.74 |
Technical Indicators
Market Signals| Indicator | ROIV | DOW |
|---|---|---|
| Relative Strength Index (RSI) | 43.41 | 51.83 |
| Support Level | $26.94 | $35.37 |
| Resistance Level | $27.94 | $42.74 |
| Average True Range (ATR) | 0.85 | 1.62 |
| MACD | -0.12 | -0.38 |
| Stochastic Oscillator | 14.42 | 51.52 |
Price Performance
Historical ComparisonAbout ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About DOW Dow Inc.
Dow Chemical is a diversified global chemicals producer, formed in 2019 as a result of the DowDuPont merger and subsequent separations. The firm is a leading producer of several chemicals, including polyethylene, ethylene oxide, and silicone rubber. Its products have numerous applications in both consumer and industrial end markets.